Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A)

Cancer Treat Rev. 1988 Jan:15 Suppl A:21-6. doi: 10.1016/0305-7372(88)90070-9.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Clinical Trials as Topic
  • Female
  • Humans
  • Interferon Type I / therapeutic use*
  • Leukemia, Myeloid / genetics
  • Leukemia, Myeloid / pathology
  • Leukemia, Myeloid / therapy*
  • Male
  • Middle Aged
  • Philadelphia Chromosome
  • Random Allocation
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use*

Substances

  • Interferon Type I
  • Recombinant Proteins